Despite clear and consistent clinical-trial evidence that secondary-prevention medical
therapies reduce mortality in patients with established coronary artery disease, these …

Background Prior studies have demonstrated that patients with high-risk acute myocardial
infarction (AMI) are less likely to receive guideline-directed medications during …

Objective To evaluate the proportion of patients hospitalised with acute coronary syndrome
(ACS) in Australia and New Zealand who received optimal inpatient preventive care and to …

BACKGROUND: Guidelines for the management of patients with acute myocardial infarction
recommend the routine use of 4 effective cardiac medications: angiotensin-converting …

Objectives: This study assessed practice variations in secondary prevention medication
prescriptions among coronary artery disease (CAD) patients treated in outpatient practices …

Acute coronary syndrome continues to be a significant cause of morbidity and mortality in
the United States. Family physicians need to identify and mitigate risk factors early, as well …

Background For patients who have had a previous myocardial infarction (MI), the use of
aspirin, β-blockers, and lipid-lowering agents reduces the risk of recurrent MI and death …

Background—Studies have examined the use of evidence-based therapies for coronary
artery disease (CAD) in the short term and at hospital discharge, but few have evaluated …

Acute coronary syndrome (ACS) describes the range of myocardial ischemic states that
includes unstable angina, non-ST elevated myocardial infarction (MI), or ST-elevated MI …

Aims Systematic data are sparse on clinical outcome after acute coronary disease followed
by cardiac rehabilitation therapy. Therefore, our objective was to determine the long-term …